Your browser doesn't support javascript.
loading
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.
Kim, Olga; Park, Eun Young; Klinkebiel, David L; Pack, Svetlana D; Shin, Yong-Hyun; Abdullaev, Zied; Emerson, Robert E; Coffey, Donna M; Kwon, Sun Young; Creighton, Chad J; Kwon, Sanghoon; Chang, Edmund C; Chiang, Theodore; Yatsenko, Alexander N; Chien, Jeremy; Cheon, Dong-Joo; Yang-Hartwich, Yang; Nakshatri, Harikrishna; Nephew, Kenneth P; Behringer, Richard R; Fernández, Facundo M; Cho, Chi-Heum; Vanderhyden, Barbara; Drapkin, Ronny; Bast, Robert C; Miller, Kathy D; Karpf, Adam R; Kim, Jaeyeon.
Afiliação
  • Kim O; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Park EY; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Klinkebiel DL; Department of Biochemistry and Molecular Biology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
  • Pack SD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Shin YH; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Abdullaev Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Emerson RE; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Coffey DM; Department of Pathology and Genomic Medicine, Houston Methodist and Weill Cornell Medical College, Houston, Texas, United States of America.
  • Kwon SY; Department of Pathology, School of Medicine, Keimyung University, Daegu, Republic of Korea.
  • Creighton CJ; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
  • Kwon S; Research and Development Center, Bioway Inc, Seoul, Republic of Korea.
  • Chang EC; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States of America.
  • Chiang T; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States of America.
  • Yatsenko AN; Department of Obstetrics, Gynecology & Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Chien J; Department of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, California, United States of America.
  • Cheon DJ; Department of Regenerative and Cancer Cell Biology, Albany Medical College, Albany, NY, United States of America.
  • Yang-Hartwich Y; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, United States of America.
  • Nakshatri H; Department of Surgery, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Nephew KP; Medical Sciences Program, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Bloomington, Indiana, United States of America.
  • Behringer RR; Departments of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Fernández FM; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
  • Cho CH; Department of Obstetrics and Gynecology, School of Medicine, Keimyung University, Daegu, Republic of Korea.
  • Vanderhyden B; Department of Cellular and Molecular Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Drapkin R; Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Bast RC; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Miller KD; Department of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine Indianapolis, Indiana, United States of America.
  • Karpf AR; Eppley Institute for Cancer Research, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
  • Kim J; Department of Biochemistry and Molecular Biology, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
PLoS Genet ; 16(6): e1008808, 2020 06.
Article em En | MEDLINE | ID: mdl-32497036

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Cistadenocarcinoma Seroso / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Cistadenocarcinoma Seroso / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos